{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T11:26:02Z","timestamp":1786879562054,"version":"build-2736575974"},"reference-count":156,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002661","name":"FRS-FNRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.rbmo.2026.105891","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:15:57Z","timestamp":1785482157000},"page":"105891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ovarian gonadotoxicity and gonadoprotection: a narrative review"],"prefix":"10.1016","volume":"53","author":[{"given":"Lara","family":"Houeis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Donnez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6331-3026","authenticated-orcid":false,"given":"Marie-Madeleine","family":"Dolmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2026.105891_bib0001","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41419-024-07202-7","article-title":"Oocyte death is triggered by the stabilization of TAp63\u03b1 dimers in response to cisplatin","volume":"15","author":"Abazarikia","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.rbmo.2026.105891_bib0002","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/fcp.12119","article-title":"Irbesartan, an angiotensin II receptor antagonist, with selective PPAR-gamma-modulating activity improves function and structure of chemotherapy-damaged ovaries in rats","volume":"29","author":"Abdel-Raheem","year":"2015","journal-title":"Fundamental & Clinical Pharmacology"},{"key":"10.1016\/j.rbmo.2026.105891_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053810","article-title":"Pharmacological Inhibition of mTORC1 Prevents Over-Activation of the Primordial Follicle Pool in Response to Elevated PI3K Signaling","volume":"8","author":"Adhikari","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.rbmo.2026.105891_bib0004","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/ddp483","article-title":"Tsc\/mTORC1 signaling in oocytes governs the quiescence and activation of primordial follicles","volume":"19","author":"Adhikari","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.rbmo.2026.105891_bib0005","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3802\/jgo.2014.25.4.328","article-title":"Granulocyte-colony stimulating factor decreases the extent of ovarian damage caused by cisplatin in an experimental rat model","volume":"25","author":"Akdemir","year":"2014","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.rbmo.2026.105891_bib0006","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/humupd\/dmz039","article-title":"The role of microRNAs in ovarian function and the transition toward novel therapeutic strategies in fertility preservation: from bench to future clinical application","volume":"26","author":"Alexandri","year":"2020","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.rbmo.2026.105891_bib0007","doi-asserted-by":"crossref","first-page":"9636","DOI":"10.1038\/s41598-019-45642-w","article-title":"MicroRNA profiling and identification of let-7a as a target to prevent chemotherapy-induced primordial follicles apoptosis in mouse ovaries","volume":"9","author":"Alexandri","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.rbmo.2026.105891_bib0008","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.3390\/ijms20194958","article-title":"Answer to Controversy: miR-10a Replacement Approaches Do Not Offer Protection against Chemotherapy-Induced Gonadotoxicity in Mouse Model","volume":"20","author":"Alexandri","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rbmo.2026.105891_bib0009","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12935-022-02706-8","article-title":"Recent advances and limitations of mTOR inhibitors in the treatment of cancer","volume":"22","author":"Ali","year":"2022","journal-title":"Cancer Cell International"},{"key":"10.1016\/j.rbmo.2026.105891_bib0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/humupd\/dmac004","article-title":"Anti-M\u00fcllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review","volume":"28","author":"Anderson","year":"2022","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.rbmo.2026.105891_bib0011","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/humrep\/deaf096","article-title":"Gonadotoxicity of immunotherapy and targeted agents in patients with cancer and impact on subsequent pregnancies","volume":"40","author":"Arecco","year":"2025","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2026.105891_bib0012","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.biotechadv.2018.03.011","article-title":"Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells - a review","volume":"36","author":"Bacakova","year":"2018","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.rbmo.2026.105891_bib0013","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10815-019-01622-7","article-title":"The role of anti-M\u00fcllerian hormone (AMH) in ovarian disease and infertility","volume":"37","author":"Bedenk","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.rbmo.2026.105891_bib0014","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41419-019-1961-y","article-title":"Kinase-independent inhibition of cyclophosphamide-induced pathways protects the ovarian reserve and prolongs fertility","volume":"10","author":"Bellusci","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.rbmo.2026.105891_bib0015","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1634\/theoncologist.2012-0172","article-title":"Chemotherapy-Induced Ovarian Failure as a Prototype for Acute Vascular Toxicity","volume":"17","author":"Ben-Aharon","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.rbmo.2026.105891_bib0016","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/s41419-018-1026-7","article-title":"C-Abl is not act\u0131vated in DNA damage-induced and Tap63-mediated oocyte apoptos\u0131s in human ovary","volume":"9","author":"Bildik","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.rbmo.2026.105891_bib0017","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/humrep\/del165","article-title":"Anti-M\u00fcllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro","volume":"21","author":"Carlsson","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2026.105891_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144245","article-title":"Cisplatin Induces Overactivation of the Dormant Primordial Follicle through PTEN\/AKT\/FOXO3a Pathway which Leads to Loss of Ovarian Reserve in Mice","volume":"10","author":"Chang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.rbmo.2026.105891_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2023.102121","article-title":"HGF-modified human umbilical cord mesenchymal stem cells rescue impaired ovarian reserve function in chemotherapy-induced POI rats by improving angiogenesis while decreasing apoptosis and fibrosis in the ovary","volume":"82","author":"Chen","year":"2023","journal-title":"Tissue and Cell"},{"key":"10.1016\/j.rbmo.2026.105891_bib0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1262\/jrd.2022-001","article-title":"Rapamycin maintains the primordial follicle pool and protects ovarian reserve against cyclophosphamide-induced damage","volume":"68","author":"Chen","year":"2022","journal-title":"J Reprod Dev"},{"key":"10.1016\/j.rbmo.2026.105891_bib0021","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13287-018-0964-4","article-title":"Heat shock pretreatment of mesenchymal stem cells for inhibiting the apoptosis of ovarian granulosa cells enhanced the repair effect on chemotherapy-induced premature ovarian failure","volume":"9","author":"Chen","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.rbmo.2026.105891_bib0022","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41409-019-0499-z","article-title":"The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation","volume":"55","author":"Ciurea","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.rbmo.2026.105891_bib0023","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ctrv.2012.12.012","article-title":"Oral and intravenously administered mTOR inhibitors for metastatic renal cell carcinoma: pharmacokinetic considerations and clinical implications","volume":"39","author":"Danesi","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.rbmo.2026.105891_bib0024","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.rbmo.2018.02.004","article-title":"Different patterns of ovarian recovery after cancer treatment suggest various individual ovarian susceptibilities to chemotherapy","volume":"36","author":"Decanter","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.rbmo.2026.105891_bib0025","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1200\/JCO.2015.65.8864","article-title":"No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial","volume":"34","author":"Demeestere","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rbmo.2026.105891_bib0026","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1200\/JCO.21.00068","article-title":"Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011)","volume":"39","author":"Demeestere","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rbmo.2026.105891_bib0027","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1007\/s10815-025-03473-x","article-title":"Anti-Mullerian hormone (AMH) protects ovarian follicle loss by downregulating granulosa cell function in in vitro and in vivo models","volume":"42","author":"Detti","year":"2025","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.rbmo.2026.105891_bib0028","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-M\u00fcllerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.rbmo.2026.105891_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8928604","article-title":"The Natural Carotenoid Crocetin and the Synthetic Tellurium Compound AS101 Protect the Ovary against Cyclophosphamide by Modulating SIRT1 and Mitochondrial Markers","volume":"2017","author":"Di Emidio","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.rbmo.2026.105891_bib0030","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.fertnstert.2004.08.035","article-title":"Efficacy of in vitro fertilization after chemotherapy","volume":"83","author":"Dolmans","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2026.105891_bib0031","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1182\/blood-2010-01-265751","article-title":"Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe","volume":"116","author":"Dolmans","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.rbmo.2026.105891_bib0032","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.fertnstert.2020.08.011","article-title":"Utility of gonadotropin-releasing hormone agonists for fertility preservation in women receiving chemotherapy: pros and cons","volume":"114","author":"Dolmans","year":"2020","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2026.105891_bib0033","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.fertnstert.2021.03.008","article-title":"Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers","volume":"115","author":"Dolmans","year":"2021","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2026.105891_bib0034","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJMra1614676","article-title":"Fertility Preservation in Women","volume":"377","author":"Donnez","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rbmo.2026.105891_bib0035","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrendo.2013.205","article-title":"Fertility preservation in women","volume":"9","author":"Donnez","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.rbmo.2026.105891_bib0036","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.fertnstert.2020.08.010","article-title":"Chemotherapy and decline of the ovarian reserve: How can we explain it and how to prevent it?","volume":"114","author":"Donnez","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2026.105891_bib0037","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9144644","article-title":"Senotherapy Protects against Cisplatin-Induced Ovarian Injury by Removing Senescent Cells and Alleviating DNA Damage","volume":"2022","author":"Du","year":"2022","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/j.rbmo.2026.105891_bib0038","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/endo.143.3.8691","article-title":"Anti-M\u00fcllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary","volume":"143","author":"Durlinger","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2026.105891_bib0039","doi-asserted-by":"crossref","first-page":"13885","DOI":"10.1096\/fj.202001461RR","article-title":"Continuous treatment with cisplatin induces the oocyte death of primordial follicles without activation","volume":"34","author":"Eldani","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.rbmo.2026.105891_bib0040","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/humrep\/deaf024","article-title":"Does gonadotoxic chemotherapy deplete the ovarian reserve through activation of primordial follicles?","volume":"40","author":"Erden","year":"2025","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2026.105891_bib0041","doi-asserted-by":"crossref","first-page":"hoaa052","DOI":"10.1093\/hropen\/hoaa052","article-title":"ESHRE guideline: female fertility preservation","volume":"2020","author":"Anderson","year":"2020","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.rbmo.2026.105891_bib0042","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.taap.2015.12.010","article-title":"The ovarian DNA damage repair response is induced prior to phosphoramide mustard-induced follicle depletion, and ataxia telangiectasia mutated inhibition prevents PM-induced follicle depletion","volume":"292","author":"Ganesan","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.rbmo.2026.105891_bib0043","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1073\/pnas.1617233114","article-title":"mTORC1\/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy","volume":"114","author":"Goldman","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.rbmo.2026.105891_bib0044","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nm.2033","article-title":"Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death","volume":"15","author":"Gonfloni","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.rbmo.2026.105891_bib0045","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ando.2010.02.021","article-title":"Human ovarian follicular development: from activation of resting follicles to preovulatory maturation","volume":"71","author":"Gougeon","year":"2010","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.rbmo.2026.105891_bib0046","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1182\/blood-2012-01-403022","article-title":"Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells","volume":"120","author":"Greve","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rbmo.2026.105891_bib0047","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/humrep\/deaf203","article-title":"Proteomic profiling reveals the molecular signatures of chemotherapy-induced human ovarian damage","volume":"40","author":"Grosbois","year":"2025","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2026.105891_bib0048","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1210\/endrev\/bnaa020","article-title":"Implications of Nonphysiological Ovarian Primordial Follicle Activation for Fertility Preservation","volume":"41","author":"Grosbois","year":"2020","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.rbmo.2026.105891_bib0049","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/humupd\/dmae020","article-title":"Ovarian microenvironment: challenges and opportunities in protecting against chemotherapy-associated ovarian damage","volume":"30","author":"Guo","year":"2024","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.rbmo.2026.105891_bib0050","first-page":"229","article-title":"Bcl2 is the guardian of microtubule integrity","volume":"57","author":"Haldar","year":"1997","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.rbmo.2026.105891_bib0051","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.fertnstert.2006.06.020","article-title":"Sphingosine 1-phosphate protects ovaries from chemotherapy-induced damage in vivo","volume":"87","author":"Hancke","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2026.105891_bib0052","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5653\/cerm.2020.03755","article-title":"Impact of imatinib or dasatinib coadministration on in vitro preantral follicle development and oocyte acquisition in cyclophosphamide-treated mice","volume":"47","author":"Hong","year":"2020","journal-title":"Clin Exp Reprod Med"},{"key":"10.1016\/j.rbmo.2026.105891_bib0053","first-page":"177","article-title":"Chemotherapy-induced diminished murine ovarian reserve model and impact of low-dose chemotherapy on fertility","volume":"6","author":"Houeis","year":"2025","journal-title":"F S Sci"},{"key":"10.1016\/j.rbmo.2026.105891_bib0054","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.fertnstert.2025.07.030","article-title":"Temsirolimus and anti-M\u00fcllerian hormone protect fertility and the ovarian reserve against chemotherapy-induced damage in a murine model","volume":"125","author":"Houeis","year":"2026","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2026.105891_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2014-1020","article-title":"Intraovarian control of early folliculogenesis","volume":"36","author":"Hsueh","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/j.rbmo.2026.105891_bib0056","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fphar.2020.00272","article-title":"Human Amniotic Fluid Mesenchymal Stem Cells Improve Ovarian Function During Physiological Aging by Resisting DNA Damage","volume":"11","author":"Huang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.rbmo.2026.105891_bib0057","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13287-018-0953-7","article-title":"Exosomes derived from human adipose mesenchymal stem cells improve ovary function of premature ovarian insufficiency by targeting SMAD","volume":"9","author":"Huang","year":"2018","journal-title":"Stem Cell Research & Therapy"},{"key":"10.1016\/j.rbmo.2026.105891_bib0058","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.fertnstert.2015.11.020","article-title":"Menses resumption after cancer treatment-induced amenorrhea occurs early or not at all","volume":"105","author":"Jacobson","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2026.105891_bib0059","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/jpi.12316","article-title":"Melatonin prevents cisplatin-induced primordial follicle loss via suppression of PTEN\/AKT\/FOXO3a pathway activation in the mouse ovary","volume":"60","author":"Jang","year":"2016","journal-title":"J Pineal Res"},{"key":"10.1016\/j.rbmo.2026.105891_bib0060","doi-asserted-by":"crossref","first-page":"185ra62","DOI":"10.1126\/scitranslmed.3005402","article-title":"Cyclophosphamide Triggers Follicle Activation and \u201cBurnout\u201d; AS101 Prevents Follicle Loss and Preserves Fertility","volume":"5","author":"Kalich-Philosoph","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.rbmo.2026.105891_bib0061","doi-asserted-by":"crossref","first-page":"E1688","DOI":"10.1073\/pnas.1620729114","article-title":"AMH\/MIS as a contraceptive that protects the ovarian reserve during chemotherapy","volume":"114","author":"Kano","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.rbmo.2026.105891_bib0062","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216291","article-title":"Overactivation or Apoptosis: Which Mechanisms Affect Chemotherapy-Induced Ovarian Reserve Depletion?","volume":"24","author":"Kashi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rbmo.2026.105891_bib0063","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/humrep\/dead064","article-title":"Dual suppression of follicle activation pathways completely prevents the cyclophosphamide-induced loss of ovarian reserve","volume":"38","author":"Kashi","year":"2023","journal-title":"Hum Reprod"},{"issue":"43","key":"10.1016\/j.rbmo.2026.105891_bib157","doi-asserted-by":"crossref","first-page":"17474","DOI":"10.1073\/pnas.1312830110","article-title":"Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment","volume":"110","author":"Kawamura","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.rbmo.2026.105891_bib0064","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.fertnstert.2007.03.065","article-title":"Does sphingosine-1-phosphate have a protective effect on cyclophosphamide- and irradiation-induced ovarian damage in the rat model?","volume":"89","author":"Kaya","year":"2008","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2026.105891_bib0065","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","article-title":"Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue","volume":"24","author":"Kern","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.rbmo.2026.105891_bib0066","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2889","article-title":"Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib","volume":"18","author":"Kerr","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.rbmo.2026.105891_bib0067","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5653\/cerm.2022.05218","article-title":"Impact of imatinib administration on the mouse ovarian follicle count and levels of intra-ovarian proteins related to follicular quality","volume":"49","author":"Kim","year":"2022","journal-title":"Clin Exp Reprod Med"},{"issue":"8","key":"10.1016\/j.rbmo.2026.105891_bib0068","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/cdd.2013.31","article-title":"Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network","volume":"20","author":"Kim","year":"2013","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.rbmo.2026.105891_bib0069","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/jnci\/djab213","article-title":"Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer Patients","volume":"114","author":"Lambertini","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.rbmo.2026.105891_bib0070","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1200\/JCO.2018.78.0858","article-title":"Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data","volume":"36","author":"Lambertini","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rbmo.2026.105891_bib0071","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.annonc.2020.09.006","article-title":"Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines","volume":"31","author":"Lambertini","year":"2020","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1016\/j.rbmo.2026.105891_bib0072","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humrep\/det391","article-title":"Sphingosine-1-phosphate prevents chemotherapy-induced human primordial follicle death","volume":"29","author":"Li","year":"2014","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.rbmo.2026.105891_bib0073","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/09513590.2017.1290072","article-title":"Sphingosine-1-phosphate activates the AKT pathway to inhibit chemotherapy induced human granulosa cell apoptosis","volume":"33","author":"Li","year":"2017","journal-title":"Gynecological Endocrinology"},{"key":"10.1016\/j.rbmo.2026.105891_bib0074","article-title":"Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Improve Ovarian Function and Proliferation of Premature Ovarian Insufficiency by Regulating the Hippo Signaling Pathway","volume":"12","author":"Li","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.rbmo.2026.105891_bib0075","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s40001-023-01231-2","article-title":"MicroRNA-144-3p protects against chemotherapy-induced apoptosis of ovarian granulosa cells and activation of primordial follicles by targeting MAP3K9","volume":"28","author":"Liu","year":"2023","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.rbmo.2026.105891_bib0076","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1530\/JOE-18-0370","article-title":"Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide","volume":"240","author":"Luan","year":"2019","journal-title":"J Endocrinol"},{"key":"10.1016\/j.rbmo.2026.105891_bib0077","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12958-022-00992-5","article-title":"hUCMSCs reduce theca interstitial cells apoptosis and restore ovarian function in premature ovarian insufficiency rats through regulating NR4A1-mediated mitochondrial mechanisms","volume":"20","author":"Luo","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.rbmo.2026.105891_bib0078","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1388-1981(02)00341-4","article-title":"Sphingosine kinase, sphingosine-1-phosphate, and apoptosis","volume":"1585","author":"Maceyka","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.rbmo.2026.105891_bib0079","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/toxsci\/kfu146","article-title":"Ovarian Xenobiotic Biotransformation Enzymes Are Altered During Phosphoramide Mustard-Induced Ovotoxicity","volume":"141","author":"Madden","year":"2014","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.rbmo.2026.105891_bib0080","first-page":"200","article-title":"Crosstalk between PTEN\/PI3K\/Akt Signalling and DNA Damage in the Oocyte: Implications for Primordial Follicle Activation","volume":"9","author":"Maidarti","year":"2020","journal-title":"Oocyte Quality and Ageing. Cells"},{"key":"10.1016\/j.rbmo.2026.105891_bib0081","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.rbmo.2026.105891_bib0082","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.3390\/cancers16122288","article-title":"Gynotoxic Effects of Chemotherapy and Potential Protective Mechanisms","volume":"16","author":"Markowska","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.rbmo.2026.105891_bib0083","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10815-019-01628-1","article-title":"Role of the PI3K and Hippo pathways in follicle activation after grafting of human ovarian tissue","volume":"37","author":"Masciangelo","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.rbmo.2026.105891_bib0084","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3390\/ijms22031395","article-title":"Asciminib Mitigates DNA Damage Stress Signaling Induced by Cyclophosphamide in the Ovary","volume":"22","author":"Mattiello","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rbmo.2026.105891_bib0086","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/humrep\/dem027","article-title":"Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury","volume":"22","author":"Meirow","year":"2007","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2026.105891_bib0087","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/humrep\/16.4.632","article-title":"Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations","volume":"16","author":"Meirow","year":"2001","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.rbmo.2026.105891_bib0088","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.fertnstert.2014.05.040","article-title":"Sphingosine-1-phosphate suppresses cyclophosphamide induced follicle apoptosis in human fetal ovarian xenografts in nude mice","volume":"102","author":"Meng","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2026.105891_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2024.108661","article-title":"Gentisic acid attenuates 5-fluorouracil-induced ovotoxicity in rats via modulating Nrf2 signalling: An experimental approach","volume":"128","author":"Mentese","year":"2024","journal-title":"Reproductive Toxicology"},{"key":"10.1016\/j.rbmo.2026.105891_bib0090","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/0002-9343(71)90341-X","article-title":"Multiple late complications of therapy with cyclophosphamide, including ovarian destruction","volume":"50","author":"Miller","year":"1971","journal-title":"Am J Med"},{"key":"10.1016\/j.rbmo.2026.105891_bib0091","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1056\/NEJMoa1413204","article-title":"Ovarian protection during adjuvant chemotherapy","volume":"372","author":"Moore","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rbmo.2026.105891_bib0092","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070117","article-title":"Cisplatin and Doxorubicin Induce Distinct Mechanisms of Ovarian Follicle Loss; Imatinib Provides Selective Protection Only against Cisplatin","volume":"8","author":"Morgan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.rbmo.2026.105891_bib0093","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2414734122","article-title":"AMH protects the ovary from doxorubicin by regulating cell fate and the response to DNA damage","volume":"122","author":"Nguyen","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.rbmo.2026.105891_bib0094","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/molehr\/gaz020","article-title":"Cisplatin- and cyclophosphamide-induced primordial follicle depletion is caused by direct damage to oocytes","volume":"25","author":"Nguyen","year":"2019","journal-title":"Molecular Human Reproduction"},{"key":"10.1016\/j.rbmo.2026.105891_bib0095","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41419-018-0633-7","article-title":"Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility","volume":"9","author":"Nguyen","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.rbmo.2026.105891_bib0096","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ijc.35383","article-title":"Pregnancy and pregnancy outcomes after adolescent and young adult cancer in the AYA horizon study","volume":"157","author":"Nichols","year":"2025","journal-title":"Int J Cancer"},{"key":"10.1016\/j.rbmo.2026.105891_bib0097","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.reprotox.2020.05.005","article-title":"The protective effects of pretreatment with resveratrol in cyclophosphamide-induced rat ovarian granulosa cell injury: In vitro study","volume":"95","author":"Nie","year":"2020","journal-title":"Reproductive Toxicology"},{"key":"10.1016\/j.rbmo.2026.105891_bib0098","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2024.104324","article-title":"Atorvastatin improves ovarian function and follicular reserve in rats with premature ovarian insufficiency","volume":"49","author":"Notghi","year":"2024","journal-title":"Reproductive BioMedicine Online"},{"key":"10.1016\/j.rbmo.2026.105891_bib0099","doi-asserted-by":"crossref","DOI":"10.2147\/CMAR.S557751","article-title":"Molecular Actions of Cyclophosphamide (CPA) in the Ovaries of Rats with Mammary Neoplasia","volume":"18","author":"Nynca","year":"2026","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.rbmo.2026.105891_bib0100","doi-asserted-by":"crossref","first-page":"10159","DOI":"10.1158\/0008-5472.CAN-07-2042","article-title":"A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve","volume":"67","author":"Oktem","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.rbmo.2026.105891_bib0101","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ctrv.2016.11.006","article-title":"Chemotherapy-related late adverse effects on ovarian function in female survivors of childhood and young adult cancer: A systematic review","volume":"53","author":"Overbeek","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.rbmo.2026.105891_bib0102","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2024.02.023","article-title":"Fertility protection: a novel approach using pretreatment with mesenchymal stem cell exosomes to prevent chemotherapy-induced ovarian damage in a mouse model","volume":"231","author":"Park","year":"2024","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.rbmo.2026.105891_bib0103","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13287-023-03397-2","article-title":"Comparison of the therapeutic effects between stem cells and exosomes in primary ovarian insufficiency: as promising as cells but different persistency and dosage","volume":"14","author":"Park","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.rbmo.2026.105891_bib0104","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13287-023-03397-2","article-title":"Comparison of the therapeutic effects between stem cells and exosomes in primary ovarian insufficiency: as promising as cells but different persistency and dosage","volume":"14","author":"Park","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.rbmo.2026.105891_bib0105","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/humrep\/dey045","article-title":"Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure","volume":"33","author":"Pascuali","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2026.105891_bib0106","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s43556-021-00041-4","article-title":"Drug resistance: from bacteria to cancer","volume":"2","author":"Patel","year":"2021","journal-title":"Molecular Biomedicine"},{"key":"10.1016\/j.rbmo.2026.105891_bib0107","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/nm1197-1228","article-title":"Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction","volume":"3","author":"Perez","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.rbmo.2026.105891_bib0108","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.taap.2011.03.012","article-title":"Detection of DNA damage in oocytes of small ovarian follicles following phosphoramide mustard exposures of cultured rodent ovaries in vitro","volume":"253","author":"Petrillo","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.rbmo.2026.105891_bib0109","doi-asserted-by":"crossref","DOI":"10.1095\/biolreprod.114.126136","article-title":"Tamoxifen Prevents Apoptosis and Follicle Loss from Cyclophosphamide in Cultured Rat Ovaries","volume":"92","author":"Piasecka-Srader","year":"2015","journal-title":"Biology of Reproduction"},{"key":"10.1016\/j.rbmo.2026.105891_bib0110","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.626322","article-title":"Stem Cell Paracrine Signaling for Treatment of Premature Ovarian Insufficiency","volume":"11","author":"Polonio","year":"2021","journal-title":"Frontiers in Endocrinology"},{"key":"10.1016\/j.rbmo.2026.105891_bib0111","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1205901","article-title":"Human UC-MSC-derived exosomes facilitate ovarian renovation in rats with chemotherapy-induced premature ovarian insufficiency","volume":"14","author":"Pu","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.rbmo.2026.105891_bib0112","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102335","article-title":"Gonadotropin Releasing Hormone agonist (GnRHa) during chemotherapy and post-cancer childbirths \u2013 a Nationwide population-based cohort study of 24,922 women diagnosed with cancer in Sweden","volume":"67","author":"Rodriguez-Wallberg","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.rbmo.2026.105891_bib0113","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s10815-019-01507-9","article-title":"Pharmacological administration of recombinant human AMH rescues ovarian reserve and preserves fertility in a mouse model of chemotherapy, without interfering with anti-tumoural effects","volume":"36","author":"Roness","year":"2019","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.rbmo.2026.105891_bib0114","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/humrep\/dead255","article-title":"Anti-Mullerian hormone attenuates both cyclophosphamide-induced damage and PI3K signalling activation, while rapamycin attenuates only PI3K signalling activation, in human ovarian cortex in vitro","volume":"39","author":"Rosario","year":"2024","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2026.105891_bib0115","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.fertnstert.2009.02.043","article-title":"Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age","volume":"94","author":"Rosendahl","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2026.105891_bib0116","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.fertnstert.2020.11.040","article-title":"Ovaries of patients recently treated with alkylating agent chemotherapy indicate the presence of acute follicle activation, elucidating its role among other proposed mechanisms of follicle loss","volume":"115","author":"Shai","year":"2021","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2026.105891_bib0117","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.rbmo.2026.105891_bib0118","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1093\/humrep\/dew224","article-title":"Factors associated with ovarian function recovery after chemotherapy for breast cancer: a systematic review and meta-analysis","volume":"31","author":"Silva","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2026.105891_bib0119","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1017\/S0967199424000315","article-title":"Resveratrol attenuates doxorubicin-induced toxicity during in vitro culture of mouse-isolated preantral follicles","volume":"32","author":"Silva","year":"2024","journal-title":"Zygote"},{"key":"10.1016\/j.rbmo.2026.105891_bib0120","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.fertnstert.2013.01.135","article-title":"Granulocyte colony-stimulating factor with or without stem cell factor extends time to premature ovarian insufficiency in female mice treated with alkylating chemotherapy","volume":"99","author":"Skaznik-Wikiel","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2026.105891_bib0121","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaf059","article-title":"Primordial follicle survival and changes in ovarian vasculature may be independently regulated during chemotherapy","volume":"166","author":"So","year":"2025","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2026.105891_bib0122","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11523-011-0174-9","article-title":"Common toxicities of mammalian target of rapamycin inhibitors","volume":"6","author":"Soefje","year":"2011","journal-title":"Target Oncol"},{"key":"10.1016\/j.rbmo.2026.105891_bib0123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/biolre\/ioaf207","article-title":"DNA damage response signaling in oocytes from an oncofertility perspective","volume":"114","author":"Song","year":"2026","journal-title":"Biol Reprod"},{"key":"10.1016\/j.rbmo.2026.105891_bib0124","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1096\/fj.201801089R","article-title":"AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice","volume":"33","author":"Sonigo","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.rbmo.2026.105891_bib0125","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dmz027","article-title":"Ovarian damage from chemotherapy and current approaches to its protection","volume":"25","author":"Spears","year":"2019","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.rbmo.2026.105891_bib0126","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/humrep\/deae221","article-title":"Anti-M\u00fcllerian hormone signaling in the ovary involves stromal fibroblasts: a study in humans and mice provides novel insights into the role of ovarian stroma","volume":"39","author":"Spector","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2026.105891_bib0127","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1002\/cncr.28942","article-title":"Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients","volume":"120","author":"Su","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.rbmo.2026.105891_bib0128","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10549-011-1593-0","article-title":"Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer","volume":"128","author":"Sverrisdottir","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.rbmo.2026.105891_bib0129","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1210\/jc.2019-00281","article-title":"Endometriosis Triggers Excessive Activation of Primordial Follicles via PI3K-PTEN-Akt-Foxo3 Pathway","volume":"104","author":"Takeuchi","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rbmo.2026.105891_bib0130","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/humrep\/deae085","article-title":"Rapamycin prevents cyclophosphamide-induced ovarian follicular loss and potentially inhibits tumour proliferation in a breast cancer xenograft mouse model","volume":"39","author":"Tanaka","year":"2024","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2026.105891_bib0131","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1538\/expanim.18-0042","article-title":"Protective effect of a mechanistic target of rapamycin inhibitor on an in vivo model ofcisplatin-induced ovarian gonadotoxicity","volume":"67","author":"Tanaka","year":"2018","journal-title":"Exp Anim"},{"key":"10.1016\/j.rbmo.2026.105891_bib0132","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10815-010-9463-y","article-title":"Tamoxifen decreases ovarian follicular loss from experimental toxicant DMBA and chemotherapy agents cyclophosphamide and doxorubicin in the rat","volume":"27","author":"Ting","year":"2010","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.rbmo.2026.105891_bib0133","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41598-020-79643-x","article-title":"Individual-oocyte transcriptomic analysis shows that genotoxic chemotherapy depletes human primordial follicle reserve in vivo by triggering proapoptotic pathways without growth activation","volume":"11","author":"Titus","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.rbmo.2026.105891_bib0134","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41594-018-0035-7","article-title":"Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63","volume":"25","author":"Tuppi","year":"2018","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.rbmo.2026.105891_bib0135","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/onco.13675","article-title":"Can Some Anticancer Treatments Preserve the Ovarian Reserve?","volume":"26","author":"Vallet","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.rbmo.2026.105891_bib0136","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1200\/JCO.2017.76.3441","article-title":"Reproductive Function and Outcomes in Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Review","volume":"36","author":"van Dorp","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rbmo.2026.105891_bib0137","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.fertnstert.2014.06.003","article-title":"Gonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: a systematic review and meta-analysis","volume":"102","author":"Vitek","year":"2014","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1016\/j.rbmo.2026.105891_bib0138","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008772","article-title":"Human ovarian reserve from conception to the menopause","volume":"5","author":"Wallace","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.rbmo.2026.105891_bib0139","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1517\/14712598.2011.574119","article-title":"Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions","volume":"11","author":"Wang","year":"2011","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1016\/j.rbmo.2026.105891_bib0140","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41388-019-1079-9","article-title":"Comparison of the different mechanisms of cytotoxicity induced by checkpoint kinase I inhibitors when used as single agents or in combination with DNA damage","volume":"39","author":"Warren","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.rbmo.2026.105891_bib0141","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1449156","article-title":"Effect of AMH on primordial follicle populations in mouse ovaries and human pre-pubertal ovarian xenografts during doxorubicin treatment","volume":"12","author":"Wei","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.rbmo.2026.105891_bib0142","article-title":"Interventions for fertility preservation in women with cancer undergoing chemotherapy","volume":"6","author":"Weterings","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rbmo.2026.105891_bib0143","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/humupd\/dmy002","article-title":"The importance of DNA repair for maintaining oocyte quality in response to anti-cancer treatments, environmental toxins and maternal ageing","volume":"24","author":"Winship","year":"2018","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.rbmo.2026.105891_bib0144","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/humrep\/dead145","article-title":"Inhibition of checkpoint kinase prevents human oocyte apoptosis induced by chemotherapy and allows enhanced tumour chemotherapeutic efficacy","volume":"38","author":"Wu","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2026.105891_bib0145","article-title":"Microenvironmentally Responsive Chemotherapeutic Prodrugs and CHEK2 Inhibitors Self-Assembled Micelles: Protecting Fertility and Enhancing Chemotherapy","volume":"35","author":"Wu","year":"2023","journal-title":"Adv Mater"},{"key":"10.1016\/j.rbmo.2026.105891_bib0146","article-title":"Exosomal miR-10a derived from amniotic fluid stem cells preserves ovarian follicles after chemotherapy","volume":"6","author":"Xiao","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.rbmo.2026.105891_bib0147","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41374-019-0321-y","article-title":"Bone marrow mesenchymal stem cell-derived exosomal miR-144-5p improves rat ovarian function after chemotherapy-induced ovarian failure by targeting PTEN","volume":"100","author":"Yang","year":"2020","journal-title":"Laboratory Investigation"},{"key":"10.1016\/j.rbmo.2026.105891_bib0148","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13048-025-01709-z","article-title":"Protective effect of ammonium trichloride tellurate (AS101) on ovarian injury induced by chemotherapy drug doxorubicin in rats","volume":"18","author":"Zhai","year":"2025","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.rbmo.2026.105891_bib0149","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/humupd\/dmv037","article-title":"Cellular and molecular regulation of the activation of mammalian primordial follicles: somatic cells initiate follicle activation in adulthood","volume":"21","author":"Zhang","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.rbmo.2026.105891_bib0150","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1158\/1535-7163.MCT-16-0511","article-title":"The BTK Inhibitor Ibrutinib (PCI-32765) overcomes paclitaxel resistance in ABCB1- & ABCC10-overexpressing cells & tumors","volume":"16","author":"Zhang","year":"2017","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/j.rbmo.2026.105891_bib0151","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41419-023-05859-0","article-title":"Chemotherapy impairs ovarian function through excessive ROS-induced ferroptosis","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.rbmo.2026.105891_bib0152","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3390\/cells10061491","article-title":"Current Understandings of Core Pathways for the Activation of Mammalian Primordial Follicles","volume":"10","author":"Zhao","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.rbmo.2026.105891_bib0153","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13048-025-01727-x","article-title":"Salvia miltiorrhiza extract ameliorated ovarian damage induced by cyclophosphamide in mice by multidimensional mechanisms","volume":"18","author":"Zhou","year":"2025","journal-title":"Journal of Ovarian Research"},{"key":"10.1016\/j.rbmo.2026.105891_bib0154","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13048-017-0350-3","article-title":"Rapamycin Prevents cyclophosphamide-induced Over-activation of Primordial Follicle pool through PI3K\/Akt\/mTOR Signaling Pathway in vivo","volume":"10","author":"Zhou","year":"2017","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.rbmo.2026.105891_bib0155","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1093\/biolre\/ioag042","article-title":"A Vaginal Microbiota-Ovary Axis in Chemotherapy-Accelerated Ovarian Aging: Single-Cell Insights into Cellular Dysregulation","volume":"114","author":"Zhou","year":"2026","journal-title":"Biol Reprod"},{"key":"10.1016\/j.rbmo.2026.105891_bib0156","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/humrep\/deae116","article-title":"Overview of crosstalk between stromal and epithelial cells in the pathogenesis of adenomyosis and shared features with deep endometriotic nodules","volume":"39","author":"Zipponi","year":"2024","journal-title":"Hum Reprod"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648326004323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648326004323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T10:53:48Z","timestamp":1786877628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648326004323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":156,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1472648326004323"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2026.105891","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian gonadotoxicity and gonadoprotection: a narrative review","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2026.105891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105891"}}